Guru Ownership Trend
Guru Analysis for Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $71.71 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $2.8 M net inflow during the quarter.
Recent activity highlights John Hussman who opened a new position. Conversely, Steven Cohen reduced exposure by 19.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Kiniksa Pharmaceuticals International, plc (KNSA)
Major holders include Steven Cohen ($30.86 M), Ken Fisher ($20.66 M), Cliff Asness ($18.23 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.48 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.8 M, with 5 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited KNSA. The total reported sell value was $7.52 M.
Yes, 2 managers opened new positions in KNSA, and 3 increased their existing holdings. The total reported buy value was $10.32 M.
